This study describes the dose response, time course, and lymphocyte requirements of procoagulant activity (PCA) induction following stimulation of thioglycolate-elicited BALB/c peritoneal macrophages with live and inactivated bacteria (Bacteroides fragiis, Escherichia coli, and Staphylococcus aureus) and murine hepatitis virus type 3 (MHV-3). Induction of PCA by MHV-3 was significantly more rapid and the maximal PCA achieved was significantly greater than by the three bacterial species studied. In relation to induction of PCA by bacteria, the PCA response was more rapid and of greater magnitude with S. aureus and E. coli than with B. fragilis. MHV-3 induced an augmented PCA response at all concentrations of virus studied in a dose-dependent fashion, whereas higher titers of live bacteria (>107 CFU/ml) inhibited PCA, suggesting the production of an inhibitory factor. Significant PCA induction was observed when macrophages were incubated with bacteria or virus in the absence of lymphocytes. At low titers of B. fragiis (103 CFU/ml), addition of lymphocytes greatly augmented PCA production, whereas at higher titers (107 CFU/ml), the addition of lymphocytes only slightly augmented the PCA response. In contrast, MHV-3 induction of PCA was enhanced by the addition of lymphocytes at all concentrations of virus studied, suggesting a lymphocyte-dependent process. Heat-inactivated bacteria were as effective as live bacteria in inducing PCA, suggesting that induction of PCA by bacteria requires only a bacterial surface component. In contrast, UV-inactivated MHV-3 did not induce PCA, suggesting that viral replication is a necessary step in PCA induction. These results suggest that the cellular and metabolic requirements for induction of PCA differ among viral and bacterial pathogens and may partly explain their differences in pathogenicity.
Extravascular fibrin deposition appears to be an important component of the host response to inflammatory stimuli (39) . During infection, fibrin plays a primary role as a bacterial sequestrant. For example, sequestration of bacteria by fibrin quantitatively diminishes the bacteremia which occurs following acute bacterial peritonitis (1, 40) . Similarly, in experimental endocarditis, foci of bacteria are present within fibrinous vegetations. Fibrin and fibrinogen degradation products may also contribute to the inflammatory response by virtue of their abilities to attract phagocytic cells into the local milieu and to modulate their function. These data, in addition to those demonstrating that anticoagulation and fibrinolysis effectively abrogate abscess formation and delayed-type hypersensitivity reactions, indicate that fibrin deposition is integral to these host responses (5, 6, 11, 31, 32) .
Macrophage-induced fibrin deposition by expression of procoagulant activity (PCA) has been demonstrated to be central to the pathogenesis of several inflammatory and infectious diseases. Macrophage PCA is responsible for augmenting the local fibrin deposition observed in delayedtype hypersensitivity, glomerulonephritis, and encephalomyelitis (7, 10, 12, 13) . Local and systemic PCA expression has been reported during experimental peritonitis (2, 3) , and both the PCA and fibrinolytic activity of monocytes were found to be augmented in patients with disseminated intravascular coagulation (8, 18, 20, 27) . PCA has been postulated to mediate fibrin deposition on infected vegetations during bacterial endocarditis (38) and has been found to correlate with susceptibility and resistance to murine hepatitis virus type 3 (MHV-3) infection (21) . * Corresponding author.
Despite the correlation between macrophage PCA expression and various infections, the mechanisms of induction of PCA by different pathogens are not well understood. PCA induction has been demonstrated to occur in response to macrophage activation by various stimuli including lipopolysaccharide, antigen-antibody complexes, and lectins (9, 16, 19, 22, 28, 30, 35) , in addition to viral pathogens such as and influenza virus (34) and bacteria such as Bacteroides fragilis, Staphylococcus aureus, and Streptococcus viridans (29) . Previous studies have differed in their conclusions about the role of lymphocytes in the induction of PCA. The following studies were designed to further elucidate and compare the pathways of PCA induction between three species of bacteria (B. fragilis, S. aureus, and Escherichia coli) and the virus MHV-3 and to determine the role of lymphocytes in PCA induction by these pathogens.
MATERIALS AND METHODS
Mice. BALB/cJ mice were obtained from Jackson Laboratory, Bar Harbor, Maine. Sera from all mice were screened for the presence of antibodies to MHV-3 in a standard radioimmunoassay, and all seropositive mice were excluded from the experiment. Similarly, exposure to B. fragilis, S. aureus, and E. coli was excluded by the absence of antibodies in an enzyme-linked immunoabsorbent assay.
Growth and culture of bacteria. B. fragilis VPI 9032 was provided by Tracy Wilkins, Virginia Polytechnic Institute and State University, Blacksburg. Aliquots were maintained frozen in thioglycolate medium without dextrose as previously described (29) . Frozen cultures were thawed, and 0.2 ml of bacterial suspension was inoculated into tubes containing 20 ml of minimal growth medium (29 (29) . Furthermore, although MHV-3-induced PCA is a prothrombinase, previous studies have shown that induction is linear and parallel to that of a rabbit brain thromboplastin standard (21 inhibition of PCA were analyzed by the signed rank test for paired samples. RESULTS Induction of PCA by bacteria. The effect of various concentrations of viable bacteria on macrophage PCA production is shown in Fig. 1. Following a 16-h incubation, B . fragilis-induced PCA production by peritoneal macrophages increased in a dose-dependent fashion, from 102 to 107 CFU/ml, achieving maximum stimulation at i07 CFU/ml. With increasing concentrations of B. fragilis (109 CFU/ml), PCA production was inhibited to near-basal levels. In contrast, S. aureus-induced PCA occurred maximally at 104 CFU/ml, and a lesser PCA response was observed at increasing concentrations of 1 to 107 CFU/ml. E. coliinduced PCA was maximal at 103 CFU/ml. With all three species, live bacterial concentrations greater than 108 CFU/ ml caused inhibition of PCA production. The viability of macrophages in the presence of 109 CFU of all three bacterial species per ml was markedly reduced (range, 50 to 60%), as assessed by trypan blue exclusion, compared with 90% viability in cultures of macrophages incubated in the absence of bacteria.
To determine whether the activation of PCA was due to release of a metabolic product of bacterial growth, we examined the dose response of PCA production by macrophages incubated with heat-killed bacteria (S. aureus, B. fragilis, and E. colt) (Fig. 2) . In contrast to the inhibitory effect of live bacteria on induction of PCA at the higher bacterial concentration, incubation with all three killed organisms resulted in a dose-dependent increase in PCA. Of particular note was the fact that maximal stimulation occurred at lo, particles per ml, the concentration at which live bacteria effected inhibition of PCA (Fig. 2) .
The time course for PCA production by macrophages following bacterial stimulation at 107 CFU of each species of bacteria per ml was studied (Fig. 3) Fig. 1 to 3) . However, to determine whether lymphocytes might amplify PCA production, we investigated the effect of lymphocytes on induction of macrophage PCA at two concentrations of B. fragilis, 103 and 107 CFU/ml. Following stimulation with the low concentration of bacteria, the addition of lymphocytes amplified the magnitude of the PCA response at all lymphocyte/ macrophage ratios, with the highest augmentation noted at a lymphocyte/macrophage ratio of 6:1 (P < 0.05) (Fig. 4) . Stimulation with B. fragilis at a lymphocyte/macrophage ratio of 6:1 resulted in an eightfold increase compared with stimulation of macrophages alone (P < 0.01) (Fig. 4) . Non-T cells failed to amplify the PCA response to any of the pathogens studied, whereas reconstitution of macrophages with T cells resulted in an augmented PCA response (Table  1) . Since our previous studies demonstrated that PCA induction by B. fragilis at 107 CFU/ml was only minimally amplified by the addition of lymphocytes (29), we hypothesized that the lymphocyte requirement also depended on bacterial number. In contrast to the small inoculum of B.
fragilis (103 CFU/ml), a large inoculum (107 CFU/ml) was able to induce near-maximal PCA in the absence of lymphocytes. Addition of lymphocytes caused a small but statistically significant further augmentation of PCA (P < 0.05). These data suggest that the lymphocyte requirement for maximal PCA induction by bacteria varies according to the quantity of the bacterial inoculum. At low concentrations, stimulation is markedly affected by the presence of lymphocytes, whereas at high concentrations induction is a relatively T-lymphocyte-independent process, but addition of lymphocytes, even at high concentrations of bacteria, results a) 0) in a statistically significant augmentation in PCA (P < 0.05) (Fig. 5) .
Induction of PCA by MHV-3. MHV-3 stimulated PCA in a dose-dependent fashion, with maximal PCA induction occurring at 106 PFU/ml (Fig. 6 ). MHV-3 appeared to be a more potent stimulus for PCA production than was any bacterial species tested, with a maximal PCA response of 6,475 ± 512 mU/106 macrophages.
Unlike studies of bacterial induction of PCA, these experiments demonstrated T-lymphocyte dependence of virusinduced PCA, regardless of the quantity of virus used. Maximal PCA was observed at lymphocyte/macrophage ratio of 6:1 and 106 PFU of MHV-3 (Fig. 7) .
The time course of PCA induction by MHV-3 was examined. Increased PCA could be seen with 103 PFU of MHV-3 at as early as 1 h of incubation, with stimulation being maximal after 6 to 8 h of incubation and remaining at near-maximum levels for 24 h (Fig. 8) .
In contrast to dead bacteria, inactivated virus caused no increase in PCA activity in either the presence or absence of lymphocytes with any concentration of UV-inactivated virus (102 to 107 PFU/ml) (data not shown).
DISCUSSION
Activation of macrophages with resulting expression of PCA has been implicated in the pathogenesis of a number of infectious diseases, including murine hepatitis infection, bacterial peritonitis and endocarditis, and the hemolyticuremic syndrome (18) . The pathways for macrophage activation by bacteria and viruses are not well characterized. The present studies demonstrated several differences between viruses and bacteria with respect to their ability to induce PCA, which may account in part for their different pathogenicities. High concentrations of live bacteria inhibited PCA induction, whereas similar concentrations of heat-killed bacteria induced a dose-dependent stimulation of PCA induction. The data suggest first that the stimulatory factor on the surface of the three bacterial species tested is heat stable and second that high concentrations of bacteria may elaborate a factor which inhibits PCA induction. Although macrophage viability was reduced by 40 to 50%, this does not totally account for the profound diminution of PCA. In this regard, recent studies from our laboratory have demonstrated that a soluble heat-stable factor produced by high concentrations of B. fragilis is able to inhibit the induction of macrophage PCA by endotoxin from E. coli (33) . Following induction of PCA by E. coli lipopolysaccharide, the addition of the bacterial supernatant did not diminish the expression of the induced PCA. This suggests that the postulated inhibitory factor prevents induction of PCA but does not block its expression or enhance its degradation (0. D. Rotstein, unpublished data). The demonstration of maximal PCA induction with lower concentrations of S. aureus and E. coli than of B. fragilis suggests that the inhibitory factor produced by the former species may be either more potent or produced in greater quantity in S. aureus and E. coli than in B. fragilis. In contrast to bacteria, increasing concentrations of MHV-3 caused a progressive increase in macrophage PCA stimulation. Furthermore, UV inactivation of MHV-3 abrogated PCA induction. These differences between MHV-3 and bacteria argue for disparate mechanisms of PCA induction by bacteria and viruses. Although bacteria appear capable of stimulating PCA via interaction with macrophages of a heat-stable surface factor, such as endotoxin or muramyl dipeptide, it appears that MHV-3 induction of PCA requires infection of macrophages by live virus. Recent studies have indicated that MHV-3-induced PCA is host generated but requires active viral replication for its production (S. Chung, S. Sinclair, J. Leibowitz, E. Skamene, and G. Levy, submitted for publication). It is known that for MHV-3 to produce disease, a virus-directed host-generated protease is involved which cleaves a surface viral glycoprotein (37) . Whether PCA has this capability in addition to its procoagulant properties requires further investigation.
The requirement for lymphocyte cooperation in PCA induction appears to vary with respect to the stimulus, the macrophage population studied, and the conditions of the experiment. In the present studies, neither bacteria nor MHV-3 demonstrated an absolute requirement for lymphocytes in PCA induction. However, with the bacterial species studied, the ability of lymphocytes to augment macrophage PCA production depended on the concentration of bacteria (17) . However, at the higher concentrations of bacteria (107 CFU/ml), the presence of lymphocytes became less important to achieving optimal PCA production. One possible explanation for this difference may relate to the bacteria-to-macrophage ratio at each bacterial concentration examined. At 107 bacteria per ml, the ratio of bacteria to macrophages (10:1) may be sufficient to induce near-maximum stimulation of macrophage PCA by direct interaction. By contrast, at 103 bacteria per ml, only 1 in 1,000 macrophages would be directly exposed to a bacterium. Amplification of the system through lymphocyte cooperation might serve to optimize PCA production. Whether this effect occurs via a soluble product of lymphocytes or via direct cellular contact requires further investigation. This suggests that at higher concentrations of bacteria, induction of PCA is a relatively lymphocyte-independent process (23) (24) (25) 36) . Although viral induction of macrophage PCA occurred in the absence of lymphocytes, there was a marked enhancement in macrophage PCA on addition of lymphocytes at all concentrations of virus studied. Previously, using peripheral blood monocytes, we demonstrated an absolute lymphocyte requirement for induction of PCA by MHV-3 (21) . The present data further support the concept that the state of monocyte-macrophage activation may be important in determining lymphocyte requirements. The requirement for lymphocyte activation has been previously shown to be dependent upon the state of activation of the monocytemacrophage, with a decreasing requirement with increasing activation (30) . Recent work in our laboratory has resulted in the development of a monoclonal antibody (3D4.3) to MHV-3-induced PCA (L. S. Fung, G. Neil, J. Leibowitz, E. H. Cole, and G. A. Levy, submitted for publication). This monoclonal antibody specifically recognizes MHV-3-induced PCA as a molecule which can directly cleave prothrombin to thrombin, i.e., a prothrombinase. By Western immunoblot analysis, 3D4.3 reacts with molecules of molecular mass 140, 74, and 70 kilodaltons, which are distinct from the demonstrated molecular mass of tissue factor (26) . Furthermore, the monoclonal antibody does not react by enzyme-linked immunosorbent assay, Western blot, or immunofluorescence with PCA induced by E. coli lipopolysaccharide which has been characterized as a tissue factor (17) . Whether the differences in the antigenic characteristics of the molecular species responsible for PCA are related to the disparate routes of PCA induction by bacteria and virus requires further investigation.
